Peptides · Peptide comparison
Chonluten vs Thymosin Alpha-1
Bronchopulmonary tripeptide bioregulator (Glu-Asp-Gly) that restores respiratory epithelial function through DNA minor groove binding at ATTTC sequences, induces TNF tolerance in alveolar macrophages reducing inflammatory cytokines by up to 6-fold, and normalizes bronchial mucosa differentiation markers in aging lung tissue
Your immune system's master trainer—a naturally occurring thymus peptide that wakes up tired immune cells, helps your body fight infections, and keeps your defenses sharp as you age.
- Immune
- Immune
At a glance
Quick comparison
Efficacy
Benefit ratings
Respiratory Tissue Repair
Lung Inflammation Control
Age-Related Lung Protection
Immune Activation
Infection Fighting
Immune Balance
Technical data
Compound specifications
Chonluten
- Molecular formula
- C11H17N3O8
- Molecular weight
- 319.27 g/mol
- Half-life
- Short plasma half-life typical of tripeptides (minutes to hours); biological effects persist for weeks to months through epigenetic modifications to bronchopulmonary gene expression; metabolized to constituent amino acids
- Bioavailability
- Absorbed via intestinal peptide transporters (PepT1) in oral formulation with enteric coating; rapid absorption from subcutaneous injection sites; efficient cellular uptake and nuclear penetration due to ultra-short tripeptide structure
- CAS number
- 75007-24-8
Thymosin Alpha-1
- Molecular formula
- C129H215N33O55
- Molecular weight
- 3108.32 g/mol
- Half-life
- Approximately 2 hours
- Bioavailability
- High when injected subcutaneously (rapid absorption, peak at ~2 hours)
- CAS number
- 62304-98-7
Protocols
Dosing compared
Chonluten
Subcutaneous
- 5-10 mgOnce daily · 10-20 days per courseFor the synthetic peptide form, a dose commonly used in research practice given as an injection under the skin. [6]
Oral
- 1-2 capsules1-2 times daily with meals · 10-30 day course, repeated 2-3 times per yearThe oral capsule plan used in practice for this bronchopulmonary peptide supplement. [6]
Thymosin Alpha-1
Subcutaneous injection
- 1.6 mgTwice weekly (3-4 days apart) · 6-12 monthsEstablished clinical dose for thymalfasin (Zadaxin); body-surface-scaled as 900 mcg/m2 [4][6]. Phase III chronic hepatitis B trials used 1.6 mg SC twice weekly for 6-12 months [4].
- 1.6 mg daily, then 1.6 mg twice weeklyDaily for an initial loading period, then twice weekly · 12+ weeksThe schedule used in a randomized trial in HBV-related acute-on-chronic liver failure: 1.6 mg daily for the first week, then twice weekly to week 12 [3].
Applications
Best suited for
Chonluten
- Respiratory health restoration in aging individuals with declining lung function
- Chonluten is particularly well-suited for individuals focused on respiratory health restoration in aging individuals with declining lung function. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Chronic bronchopulmonary conditions requiring tissue-level regenerative support
- Chonluten is particularly well-suited for individuals focused on chronic bronchopulmonary conditions requiring tissue-level regenerative support. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Comprehensive Khavinson bioregulator protocols targeting respiratory and immune function
- Chonluten is particularly well-suited for individuals focused on comprehensive khavinson bioregulator protocols targeting respiratory and immune function. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Geroprotective therapy for lung tissue preservation in elderly populations
- Chonluten is particularly well-suited for individuals focused on geroprotective therapy for lung tissue preservation in elderly populations. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Thymosin Alpha-1
- Chronic Hepatitis B or C Support
- Thymosin Alpha-1 has its strongest clinical evidence here. Multiple trials show it helps clear viral loads and normalize liver enzymes, especially when combined with antiviral medications. It's approved in over 30 countries specifically for hepatitis treatment.
- Cancer Treatment Support
- When used alongside chemotherapy, Thymosin Alpha-1 may help maintain immune function that chemo tends to suppress. Research in lung cancer, melanoma, and liver cancer shows improved outcomes when added to standard treatments. It helps your immune system keep fighting even during tough treatments.
- Age-Related Immune Decline
- As you age, your thymus shrinks and produces less thymosin naturally—a process called immunosenescence. Supplementing with Thymosin Alpha-1 may help compensate, keeping your immune defenses more youthful and responsive. Think of it as replacing what your body makes less of over time.
- Severe Infection Recovery
- In sepsis and critical infections, Thymosin Alpha-1 has shown promise for reducing mortality by helping restore immune balance. It's particularly interesting because it modulates immunity rather than just boosting it—calming overreaction while enhancing pathogen-fighting ability.
Safety profile
Side effects
Chonluten
Common
- Injection site reaction
- Mild fatigue
- Transient respiratory changes
- Mild headache
Uncommon
- Flu-like symptoms
Serious
- No documented serious adverse effects
Thymosin Alpha-1
Common
- Injection site reactions
Uncommon
- Mild fatigue
- Flu-like symptoms
- Mild fever
- Lymph node awareness
Serious
- Allergic reaction
Research status
Safety & evidence
Chonluten
- Evidence level
- Limited human trials
- FDA status
- Research compound
- Safety overview
- Chonluten is a cartilage-derived peptide extract used primarily in Russian and Eastern European medicine that lacks FDA approval and rigorous clinical safety data. As a poorly defined mixture of collagen peptides and proteoglycans from cartilage tissue, standardization and batch consistency cannot be guaranteed. Potential risks include allergic reactions to connective tissue proteins, contamination from animal tissues, and unknown immunological effects from proteoglycan components. No formal safety assessments, animal toxicology studies by modern standards, or human Phase 1/2 trials exist. Long-term safety outcomes are completely unstudied.
Contraindications
- Known hypersensitivity to peptide bioregulators or constituent amino acids (glutamic acid, aspartic acid, glycine)
- Pregnancy and breastfeeding — insufficient reproductive safety data
- Active pulmonary infections requiring immediate medical treatment
- Severe immunosuppression without medical supervision — immunomodulatory effects may be unpredictable
Thymosin Alpha-1
- Evidence level
- Moderate human trials (Phase 1-2)
- FDA status
- Not FDA approved. There is no thymalfasin application in Drugs@FDA. It is used outside the US (as Zadaxin) for chronic hepatitis B and as an immune adjuvant.
- Safety overview
- Thymosin Alpha-1 has one of the most extensive safety records of any peptide, with decades of clinical use across multiple countries. Studies consistently report minimal side effects—mostly limited to mild injection site reactions. The 2-hour half-life means it doesn't accumulate in your system. It's been used safely in thousands of patients with hepatitis, cancer, and other serious conditions.
Contraindications
- Organ transplant recipients on immunosuppressants
- Active autoimmune disease flares
- Known allergy to thymosin peptides
- Pregnancy or breastfeeding
- Children under 18 without medical supervision
Decision guide
Which is right for you?
Chonluten
Choose Chonluten if…
- Respiratory health restoration in aging individuals with declining lung function
- Chronic bronchopulmonary conditions requiring tissue-level regenerative support
- Comprehensive Khavinson bioregulator protocols targeting respiratory and immune function
- Geroprotective therapy for lung tissue preservation in elderly populations
Thymosin Alpha-1
Choose Thymosin Alpha-1 if…
- Immune system strengthening
- Chronic infection support
- Cancer adjunct therapy
- Healthy aging immune support